Stelara 90MG/ML SYR 1S
Ended Awarded
- Contract number
- SPE2DX25FKWCD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $43,634
Award facts
- Contract value 100% obligated
- $43,634.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $43,634.10 for Stelara 90mg/ml syringes by the Department of Defense Medical Supply Chain. The contract, awarded on September 24, 2025, with an ultimate completion date of October 22, 2025, represents a direct purchase under the company's existing Indefinite Delivery Contract with the Defense Logistics Agency. This delivery order carries no set-aside designation and will be performed at the contractor's facility in Park Ridge, Illinois.
This award is issued under DMS Pharmaceutical Group's larger single-award IDC with the Defense Logistics Agency's SPE2DB program, a $499.999 billion contract vehicle valid through November 2026 that enables the agency to procure pharmaceutical products and medical supplies for military health facilities worldwide. Stelara, a biologic immunosuppressant medication, represents the type of specialty pharmaceutical product within the contractor's extensive portfolio of branded and generic prescription drugs, biologics, and medical consumables. As a consistent federal contractor with demonstrated capabilities in pharmaceutical distribution to Department of Defense healthcare sites, DMS Pharmaceutical Group continues to serve as a critical supplier within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DX25FKWCD?
SPE2DX25FKWCD was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 24, 2025.
How much is contract SPE2DX25FKWCD worth?
The government has obligated $43,634 on SPE2DX25FKWCD.
Is contract SPE2DX25FKWCD an order under another contract?
Yes. SPE2DX25FKWCD is a delivery order under SPE2DX15D9628, an indefinite delivery contract.
Was contract SPE2DX25FKWCD competed?
The extent of competition for SPE2DX25FKWCD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award